No Barrier Medical Translation has secured $27 in new funding from investors. The company specializes in providing an AI-powered medical interpreter platform designed to address critical language barriers within healthcare settings.
Language barriers present significant challenges in healthcare, leading to slower care delivery, increased risks, higher costs, and a diminished patient experience. Traditional human interpreters can be difficult to schedule, expensive per minute, and inconsistent, particularly outside of standard hours. No Barrier Medical Translation offers a solution through its real-time speech-to-speech interpretation platform, enabling instant communication between healthcare providers and limited English proficiency (LEP) patients.
The platform is built for clinical accuracy and HIPAA compliance, integrating safety controls such as easy escalation to a human interpreter when necessary. It provides 24/7 on-demand interpreting across more than 30 languages and dialects, accessible on devices healthcare teams already use. This technology aims to deliver consistent quality for common clinical encounters, enhance operational efficiency by reducing interpreter spend, and shorten encounter times, all while ensuring compliance with privacy-by-design principles.
This capital infusion of $27 will be instrumental in accelerating No Barrier Medical Translation's product development and expanding its market presence. The funding underscores investor confidence in the company's approach to leveraging artificial intelligence to solve critical communication gaps in the medical field.
Looking ahead, No Barrier Medical Translation plans to further scale its operations and enhance its AI capabilities to serve a broader range of hospitals, clinics, and healthcare networks. The company is focused on continuing to improve healthcare language access and reduce operational costs for providers, ultimately aiming to improve patient outcomes and experiences nationwide.
